322 related articles for article (PubMed ID: 20213343)
1. Cyclic GMP and nitric oxide synthase in aging and Alzheimer's disease.
Domek-Łopacińska KU; Strosznajder JB
Mol Neurobiol; 2010 Jun; 41(2-3):129-37. PubMed ID: 20213343
[TBL] [Abstract][Full Text] [Related]
2. Modulating nitric oxide signaling in the CNS for Alzheimer's disease therapy.
Zhihui Q
Future Med Chem; 2013 Aug; 5(12):1451-68. PubMed ID: 23919554
[TBL] [Abstract][Full Text] [Related]
3. Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum. Effects of amyloid beta peptide.
Chalimoniuk M; Strosznajder JB
Mol Chem Neuropathol; 1998; 35(1-3):77-95. PubMed ID: 10343972
[TBL] [Abstract][Full Text] [Related]
4. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
de Vente J; Markerink-van Ittersum M; Vles JS
J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of nitric oxide-cyclic GMP signalling in CNS cells and its possible regulation by cyclic GMP.
Wykes V; Bellamy TC; Garthwaite J
J Neurochem; 2002 Oct; 83(1):37-47. PubMed ID: 12358727
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase type 2 and the homeostasis of cyclic GMP in living thalamic neurons.
Hepp R; Tricoire L; Hu E; Gervasi N; Paupardin-Tritsch D; Lambolez B; Vincent P
J Neurochem; 2007 Sep; 102(6):1875-1886. PubMed ID: 17561940
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-cyclic GMP pathway with some emphasis on cavernosal contractility.
Ghalayini IF
Int J Impot Res; 2004 Dec; 16(6):459-69. PubMed ID: 15229623
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthase and cyclic GMP signaling in cardiac myocytes: from contractility to remodeling.
Hammond J; Balligand JL
J Mol Cell Cardiol; 2012 Feb; 52(2):330-40. PubMed ID: 21843527
[TBL] [Abstract][Full Text] [Related]
9. Homogeneous single-label cGMP detection platform for the functional study of nitric oxide-sensitive (soluble) guanylyl cyclases and cGMP-specific phosphodiesterases.
Kopra K; Sharina I; Martin E; Härmä H
Sci Rep; 2020 Oct; 10(1):17469. PubMed ID: 33060787
[TBL] [Abstract][Full Text] [Related]
10. Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways.
Padovan-Neto FE; Sammut S; Chakroborty S; Dec AM; Threlfell S; Campbell PW; Mudrakola V; Harms JF; Schmidt CJ; West AR
J Neurosci; 2015 Apr; 35(14):5781-91. PubMed ID: 25855188
[TBL] [Abstract][Full Text] [Related]
11. Enzyme activities of the nitric oxide-cGMP pathway in corpus cavernosum isolated from middle-aged rats.
Hosogai N; Takakura S; Manda T; Mutoh S
Eur J Pharmacol; 2003 Jul; 473(1):65-70. PubMed ID: 12877939
[TBL] [Abstract][Full Text] [Related]
12. Role of the nitric oxide-soluble guanylyl cyclase pathway in obstructive airway diseases.
Dupont LL; Glynos C; Bracke KR; Brouckaert P; Brusselle GG
Pulm Pharmacol Ther; 2014 Oct; 29(1):1-6. PubMed ID: 25043200
[TBL] [Abstract][Full Text] [Related]
13. Targeting NO/cGMP Signaling in the CNS for Neurodegeneration and Alzheimer's Disease.
Ben Aissa M; Lee SH; Bennett BM; Thatcher GR
Curr Med Chem; 2016; 23(24):2770-2788. PubMed ID: 27776476
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3',5'-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study.
Lee NP; Cheng CY
Endocrinology; 2003 Jul; 144(7):3114-29. PubMed ID: 12810568
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal AMPA- and NMDA-induced cGMP signals are mainly generated by NO-GC2 and are under tight control by PDEs 1 and 2.
Giesen J; Mergia E; Koesling D; Russwurm M
Eur J Neurosci; 2022 Jan; 55(1):18-31. PubMed ID: 34902209
[TBL] [Abstract][Full Text] [Related]
16. Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.
Hussain MB; Hobbs AJ; MacAllister RJ
Br J Pharmacol; 1999 Nov; 128(5):1082-8. PubMed ID: 10556946
[TBL] [Abstract][Full Text] [Related]
17. sGC-cGMP signaling: target for anticancer therapy.
Bian K; Murad F
Adv Exp Med Biol; 2014; 814():5-13. PubMed ID: 25015797
[TBL] [Abstract][Full Text] [Related]
18. Formalin injection causes a coordinated spinal cord CO/NO-cGMP signaling system response.
Shi X; Li X; Clark JD
Mol Pain; 2005 Nov; 1():33. PubMed ID: 16297238
[TBL] [Abstract][Full Text] [Related]
19. Cyclic GMP metabolism and its role in brain physiology.
Domek-Łopacińska K; Strosznajder JB
J Physiol Pharmacol; 2005 Mar; 56 Suppl 2():15-34. PubMed ID: 16077188
[TBL] [Abstract][Full Text] [Related]
20. Endurance training upregulates the nitric oxide/soluble guanylyl cyclase/cyclic guanosine 3',5'-monophosphate pathway in the striatum, midbrain and cerebellum of male rats.
Chalimoniuk M; Chrapusta SJ; Lukačova N; Langfort J
Brain Res; 2015 Aug; 1618():29-40. PubMed ID: 26006108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
